117 related articles for article (PubMed ID: 22244910)
1. Age- and gender-related differences in the use of secondary medical prevention after primary vascular surgery: a nationwide follow-up study.
Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):300-7. PubMed ID: 22244910
[TBL] [Abstract][Full Text] [Related]
2. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
3. Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment.
Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
Eur J Prev Cardiol; 2013 Oct; 20(5):763-70. PubMed ID: 22637739
[TBL] [Abstract][Full Text] [Related]
4. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
5. Use of angiotensin-converting enzyme inhibitors and cardiovascular outcomes following primary vascular surgery: a nationwide propensity score matched follow-up study.
Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
Vasc Endovascular Surg; 2012 Oct; 46(7):515-23. PubMed ID: 22843293
[TBL] [Abstract][Full Text] [Related]
6. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
7. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
8. No gender differences in prognosis and preventive treatment in patients with AMI without significant stenoses.
Hansen KW; Hvelplund A; Abildstrøm SZ; Prescott E; Madsen M; Madsen JK; Jensen JS; Thuesen L; Thayssen P; Tilsted HH; Jørgensen E; Galatius S
Eur J Prev Cardiol; 2012 Aug; 19(4):746-54. PubMed ID: 21724682
[TBL] [Abstract][Full Text] [Related]
9. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
10. Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study.
Sjölander M; Eriksson M; Glader EL
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):911-9. PubMed ID: 22069216
[TBL] [Abstract][Full Text] [Related]
11. Treatment of 5413 hypertensive patients: a cross-sectional study.
Paulsen MS; Sondergaard J; Reuther L; Larsen PS; Munck AP; Larsen PV; Damsgaard J; Poulsen L; Hansen DG; Jacobsen IA; Larsen ML; Christensen HR; Christensen B; Andersen M
Fam Pract; 2011 Dec; 28(6):599-607. PubMed ID: 21596691
[TBL] [Abstract][Full Text] [Related]
12. Ischemic heart disease and primary care: identifying gender-related differences. An observational study.
Cruz I; Serna C; Real J; Galindo G; Gascó E; Galván L
BMC Fam Pract; 2008 Oct; 9():60. PubMed ID: 18973693
[TBL] [Abstract][Full Text] [Related]
13. [Reduction in 28 days and 6 months of acute myocardial infarction mortality from 1995 to 2005. Data from PRIAMHO I, II and MASCARA registries].
Arós F; Heras M; Vila J; Sanz H; Ferreira-González I; Permanyer-Miralda G; Cuñat J; López-Bescós L; Cabadés A; Loma-Osorio A; Marrugat J;
Rev Esp Cardiol; 2011 Nov; 64(11):972-80. PubMed ID: 21803474
[TBL] [Abstract][Full Text] [Related]
14. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
15. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
16. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
17. [The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age].
Kolloch RE; Rahn KH
Dtsch Med Wochenschr; 1998 Jan; 123(1-2):1-5. PubMed ID: 9465848
[TBL] [Abstract][Full Text] [Related]
18. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
[TBL] [Abstract][Full Text] [Related]
19. Changing patterns of secondary preventive medication among newly diagnosed coronary heart disease patients with diabetes in Finland: a register-based study.
Vehko T; Manderbacka K; Arffman M; Sund R; Reunanen A; Keskimäki I
Scand J Public Health; 2010 May; 38(3):317-24. PubMed ID: 20228159
[TBL] [Abstract][Full Text] [Related]
20. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
